<DOC>
	<DOCNO>NCT02665273</DOCNO>
	<brief_summary>This randomize , sham-controlled study great occipital nerve block ( GONB ) use bupivacaine 0.5 % emergency department patient acute migraine . Patients enrol fail first line therapy metoclopramide .</brief_summary>
	<brief_title>Greater Occipital Nerve Block With Bupivacaine Acute Migraine</brief_title>
	<detailed_description>The investigator test follow hypothesis : In population patient present ED acute migraine treat parenteral metoclopramide unsuccessfully , bilateral great occipital nerve block bupivicaine provide great rate short-term sustained headache freedom bupivacaine inject intradermally .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>ED patient acute migraine probable migraine Fail first line therapy metoclopramide Ca n't obtain consent Concern secondary headache Skull defect Propensity bleed Overlying infection Pregnancy Allergy , intolerance study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>